Hangzhou Tigermed Consulting Co Ltd 每股年股息為 0.7408,收益率為 0.00%。股息每 每年 支付,最後除權日為 Jun 12, 2025。
股息收益率
年度股息
除息日
0.00%
$0.7408
Jun 12, 2025
付款頻率
派息比例
每年
0.00%
股利歷史
除息日
現金金額
記錄日期
付款日
Jun 12, 2025
$0.3245
Jun 13, 2025
Jul 11, 2025
Jun 7, 2024
$0.6237
Jun 11, 2024
Jul 18, 2024
May 25, 2023
$0.6156
May 29, 2023
Jul 7, 2023
May 24, 2022
$0.5796
May 25, 2022
Jun 20, 2022
股利圖表
HTMDF 股利
HTMDF 股息增長(年增率)
Follow-Up Questions
Hangzhou Tigermed Consulting Co Ltd 當前的股息支付和年度股息是多少?
Hangzhou Tigermed Consulting Co Ltd 的股息支付比率是多少?
HTMDF 的除息日是什麼?
Hangzhou Tigermed Consulting Co Ltd 多久支付一次股息?
關鍵數據
前收市價
--
開盤價
--
當日範圍
-
52週區間
-
交易量
--
平均成交量
--
每股盈餘 (TTM)
--
股息收益率
--
市值
--
什麼是 HTMDF?
Hangzhou Tigermed Consulting Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Hangzhou, Zhejiang and currently employs 10,185 full-time employees. The company went IPO on 2012-08-17. Hangzhou Tigermed Consulting Co Ltd is a China-based holding company engaged in providing clinical trial services for research and development of new drugs. The firm operates two segments. The Clinical Trial Solutions segment provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies and thus help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical-Related and Laboratory Services segment is involved in provision of analytical services, such as data management and statistical analysis; logistics and execution support services, such as clinical trial site management; administrative assistance, such as patient recruitment; as well as consulting services. This segment also provides laboratory services for preclinical and clinical development stages through its subsidiary. The firm conducts its businesses in the domestic and overseas markets.